Every patient in a Yale clinical trial of a new treatment for the disfiguring disease sarcoidosis saw an improvement in their skin — and more than half showed improvement in affected internal organs. Sarcoidosis is a disease affecting four out of every 10,000 people in the United States. In sarcoidosis, abnormal collections of immune cells called granulomas...
Tag: <span>JAK inhibitor</span>
Post
Latest JAK inhibitor trials for severe skin disease are a success
by Jim Shelton, Yale University Before and after images for participants who received 36 weeks of treatment for alopecia areata with baricitinib. Credit: Yale University A new study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug. The study is...